Browse result page of THPdb

The total number entries retrieved from this search are 89

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1445	ThPPIDTh1079	NameSerum Albumin	Peptide SequenceDAHKSEVAHRFKDLGEENFK Full view	Length585	Functional ClassificationIV	DiseaseMetabolic/genetic	BrandAlbunex	CompanyMallinckrodt; Tyco Healthcare	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategorySerum substitutes	TargetN.A.
ID1446	ThPPIDTh1079	NameSerum Albumin	Peptide SequenceDAHKSEVAHRFKDLGEENFK Full view	Length585	Functional ClassificationIV	DiseaseMetabolic/genetic	BrandOptison	CompanyGE Healthcare	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategorySerum substitutes	TargetN.A.
ID1453	ThPPIDTh1083	NameCoagulation Factor Ix	Peptide SequenceYNSGKLEEFVQGNLERECME Full view	Length415	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlprolix	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, non-pyrogenic, preservative-free, white to off-white, lyophilized powder to cake for reconstitution with the provided diluent	Route of AdministartionIntravenous infusion	CategoryCoagulants and Thrombotic Agents	TargetN.A.
ID1455	ThPPIDTh1085	NameAgalsidase Beta	Peptide SequenceLDNGLARTPTMGWLHWERFM Full view	Length398	Functional ClassificationIa	DiseaseMetabolic	BrandFabrazyme	CompanyGenzyme Corp	Physical AppearanceSterile, nonpyrogenic, white to off-white, lyophilized cake or powder for reconstitution with Sterile Water for Injection	Route of AdministartionN.A.	CategoryEnzyme Replacement Agents	TargetN.A.
ID1476	ThPPIDTh1096	NameIdursulfase	Peptide SequenceSETQANSTTDALNVLLIIVD Full view	Length525	Functional ClassificationIa	DiseaseMetabolic	BrandElaprase	CompanySHIRE	Physical AppearanceSterile, nonpyrogenic clear to slightly opalescent, colorless solution that must be diluted prior to administration in 0.9% Sodium Chloride Injection, USP	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetDermatan sulfate,Heparan sulfate,Perilipin-3
ID1477	ThPPIDTh1097	NameAlglucosidase Alfa	Peptide SequenceAHPGRPRAVPTQCDVPPNSR Full view	Length882	Functional ClassificationIc	DiseaseMetabolic	BrandLUMIZYME	CompanyGenzyme	Physical AppearanceSterile, nonpyrogenic, white to off-white, lyophilized cake or powder for reconstitution with 10.3 Ml Sterile Water for Injection, USP	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetCation-dependent mannose-6-phosphate receptor,Glycogen
ID1478	ThPPIDTh1098	NameExenatide	Peptide SequenceHGEGTFTSDLSKQMEEEAVR Full view	Length39	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBYETTA	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryHypoglycemic Agents	TargetGlucagon-like peptide 1 receptor
ID1479	ThPPIDTh1098	NameExenatide	Peptide SequenceHGEGTFTSDLSKQMEEEAVR Full view	Length39	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBYDUREON	CompanyAmylin Pharmaceuticals	Physical AppearanceWhite to off-white powder that is available in a dosage strength of 2 mg exenatide per vial or per pen	Route of AdministartionN.A.	CategoryHypoglycemic Agents	TargetGlucagon-like peptide 1 receptor
ID1482	ThPPIDTh1100	NamePramlintide	Peptide SequenceKCNTATCATQRLANFLVHSS Full view	Length37	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandSymlin	CompanyAmylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)	Physical AppearanceClear, isotonic, sterile solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetCalcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3
ID1494	ThPPIDTh1101	NameGalsulfase	Peptide SequenceSGAGASRPPHLVFLLADDLG Full view	Length497	Functional ClassificationIa	DiseaseMetabolic	BrandNaglazyme	CompanyBioMarin	Physical AppearanceSterile, nonpyrogenic, colorless to pale yellow, clear to slightly opalescent solution that must be diluted with 0.9% Sodium Chloride Injection, USP, prior to administration	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetDermatan sulfate,Perilipin-3
ID1502	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog	CompanyNovo Nordisk	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous injection, Intravenous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1503	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 50/50	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1504	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 70/30	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart 100 Units/mL.	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1511	ThPPIDTh1106	NameInsulin Detemir	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandLEVEMIR	CompanyNovo Nordisk	Physical AppearanceClear, colorless, aqueous, neutral sterile solution	Route of AdministartionSubcutaneous injection	CategoryAntidiabetic Agents	TargetInsulin receptor
ID1520	ThPPIDTh1107	NameInsulin Glulisine	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandAPIDRA	Companysanofi-aventis	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionN.A.	CategoryAntidiabetic Agents	TargetInsulin receptor
ID1634	ThPPIDTh1140	NameInsulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn)	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovolin N	CompanyNovo Nordisk	Physical AppearanceNovolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe)	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1648	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekturna	CompanyPhysicians Total Care, Inc.	Physical AppearanceLight-pink, biconvex round tablet	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1649	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekturna	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceLight-pink, biconvex round tablet	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1650	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekturna HCT	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceBiconvex, ovaloid film-coated tablets.	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1651	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekamlo	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceTablets (aliskiren/amlodipine): 150 mg/5 mg, 150 mg/10 mg, 300 mg/5 mg, 300 mg/10 mg	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1652	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandAmturnide	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceTablets (aliskiren/ amlodipine/ HCTZ): 150/5/12.5, 300/5/12.5, 300/5/25, 300/10/12.5, 300/10/25 mg.ÂÂÂ	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1655	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandNutropinAQ	CompanyGenentech Inc.	Physical AppearanceSterile, white lyophilized powder intended for subcutaneous administration after reconstitution with Bacteriostatic Water	Route of AdministartionSubcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1656	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBioTropin	CompanyBio-Technology General (Israel) Ltd.	Physical AppearanceSterile, white, lyophilized powder	Route of AdministartionSubcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1657	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandProtropin	CompanyGenentech Inc.	Physical AppearanceSterile, white, lyophilized powder	Route of AdministartionIntramuscular or subcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1678	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis U.S. Llc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 9
ID1679	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 10
ID1680	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 11
ID1681	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis U.S. Llc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 14
ID1729	ThPPIDTh1176	NameDulaglutide	Peptide SequenceHGEGTFTSDVSSYLEEQAAK Full view	Length275	Functional ClassificationIb	DiseaseMetabolic Disorders	BrandTrulicity	CompanyEli Lilly and Company	Physical AppearanceSolution, Injection	Route of AdministartionSubcutaneous	CategoryHypoglycemic Agents; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins	TargetGlucagon-like peptide 1 receptor
ID1730	ThPPIDTh1176	NameDulaglutide	Peptide SequenceHGEGTFTSDVSSYLEEQAAK Full view	Length275	Functional ClassificationIb	DiseaseMetabolic Disorders	BrandTrulicity	CompanyEli Lilly Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryHypoglycemic Agents; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins	TargetGlucagon-like peptide 1 receptor
ID1736	ThPPIDTh1177	NameElosulfase alfa	Peptide SequenceAPQPPNILLLLMDDMGWGDL Full view	Length496	Functional ClassificationIa	DiseaseMetabolic Disorders	BrandVimizim	CompanyBiomarin International Limited	Physical AppearanceSolution	Route of AdministartionIntravenous	CategoryEnzymes; Alimentary Tract and Metabolism	TargetN-acetylgalactosamine-6-sulfatase
ID1741	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandNA	CompanyNA	Physical AppearanceInjection, Solution; Injection	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 9
ID1742	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Inc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 10
ID1743	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 11
ID1744	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Inc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 12
ID1821	ThPPIDTh1212	NameInsulin Pork	Peptide SequenceA chain GIVEQCCTSICS Full view	Length68	Functional ClassificationIa	DiseaseMetabolic Disorders	BrandIletin II	CompanyLilly	Physical Appearancesterile suspension	Route of AdministartionSubcutaneous	CategoryHypoglycemic Agents, Antidiabetic Agents	TargetInsulin receptor, Insulin-like growth factor 1 receptor, Insulin-degrading enzyme, HLA class II histocompatibility antigen, DQ alpha 2 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, Retinoblastoma-associated protein, Cathepsin D, Carboxypeptidase E, Neuroendocrine convertase 2, Neuroendocrine convertase 1, Protein NOV homolog, Low-density lipoprotein receptor-related protein 2, Insulin-like growth factor-binding protein 7, Synaptotagmin-like protein 4, Cytochrome P450 1A2
ID1822	ThPPIDTh1213	NameInsulin Degludec	Peptide SequenceInsulin degludec dif Full view	Length0	Functional ClassificationIa	DiseaseMetabolic Disorders	BrandTresiba	CompanyNovo Nordisk	Physical Appearancesterile, aqueous, clear, and colorless Solution	Route of AdministartionSubcutaneous	CategoryNA	TargetNA
ID1823	ThPPIDTh1214	NameInsulin Beef	Peptide SequenceA chain: GIVEQCCASVC Full view	Length71	Functional ClassificationIa	DiseaseMetabolic Disorders	BrandNA	CompanyNA	Physical AppearanceNA	Route of AdministartionNA	CategoryNA	TargetNA
ID1847	ThPPIDTh1235	NameProtein S human	Peptide SequenceANSLLEETKQGNLERECIEE Full view	Length635	Functional ClassificationIb	DiseaseMetabolic Disorders	BrandProtein S human	CompanyNA	Physical Appearance Solid	Route of AdministartionNA	CategoryAnticoagulant plasma protein	TargetNA